Tapan K. Bera

Immunology and MicrobiologyBiochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Immunotherapy-based targeting of MSLN + activated portal fibroblasts is a strategy for treatment of cholestatic liver fibrosis”.

Immunotherapy-based targeting of MSLN + activated portal fibroblasts is a strategy for treatment of cholestatic liver fibrosis

Proceedings of the National Academy of Sciences(2021)10.1073/pnas.2101270118

N/A

0DataRank · unranked

29 citations

Yukinori Koyama, Xiao Liu, Sara Brin Rosenthal, Gen Yamamoto, Hiroaki Fuji +12 more

Highly active CAR T cells that bind to a juxtamembrane region of mesothelin and are not blocked by shed mesothelin

Proceedings of the National Academy of Sciences(2022)10.1073/pnas.2202439119

N/A

0DataRank · unranked

50 citations

Masanori Onda, Nathan Watson, Raffit Hassan, Mitchell Ho, Tapan K. Bera +10 more

A Bispecific Antibody That Targets the Membrane-Proximal Region of Mesothelin and Retains High Anticancer Activity in the Presence of Shed Mesothelin

Molecular Cancer Therapeutics(2024)10.1158/1535-7163.mct-23-0233

N/A

0DataRank · unranked

11 citations

Masanori Onda, T. O’Shea, Junxia Wei, Xiufen Liu, Tapan K. Bera +2 more